share_log
Breakings ·  Dec 13 05:20
Repare Therapeutics Inc - to Initiate Phase 3 Trial of Lunresertib and Camonsertib in 2H 2025
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment